Back to search
FDAFDA · Food and drugs·Recall number D-1363-2020

Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Published July 8, 2020 · Recall initiated: June 9, 2020

Summary

FDA records drug Class I recall D-1363-2020, published July 8, 2020 and initiated June 9, 2020. Recalling firm: MasterPharm LLC; Status: Terminated; Reported quantity: 300 capsules; Lot: Lot #: 01-09-2020:13@8, Exp. 7/7/2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MasterPharm LLC
Distributor
FL and MD
Lot
Lot #: 01-09-2020:13@8, Exp. 7/7/2020
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419. recalled?

Yes. FDA published recall D-1363-2020 on July 8, 2020. Reported hazard: Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.

What should I do if I have this product?

Voluntary: Firm initiated · Letter